Literature DB >> 14688409

Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo.

Donna Hochberg1, Jaap M Middeldorp, Michelle Catalina, John L Sullivan, Katherine Luzuriaga, David A Thorley-Lawson.   

Abstract

Epstein-Barr virus (EBV) is a herpesvirus that establishes a lifelong, persistent infection. It was first discovered in the tumor Burkitt's lymphoma (BL). Despite intensive study, the role of EBV in BL remains enigmatic. One striking feature of the tumor is the unique pattern of viral latent protein expression, which is restricted to EBV-encoded nuclear antigen (EBNA) 1. EBNA1 is required to maintain the viral genome but is not recognized by cytotoxic T cells. Consequently, it was proposed that this expression pattern was used by latently infected B cells in vivo. This would be the site of long-term, persistent infection by the virus and, by implication, the progenitor of BL. We now know that EBV persists in memory B cells in the peripheral blood and that BL is a tumor of memory cells. However, a normal B cell expressing EBNA1 alone has been elusive. Here we show that most infected cells in the blood express no detectable latent mRNA or proteins. The exception is that when infected cells divide they express EBNA1 only. This is the first detection of the BL viral phenotype in a normal, infected B cell in vivo. It suggests that BL may be a tumor of a latently infected memory B cell that is stuck proliferating because it is a tumor and, therefore, constitutively expressing only EBNA1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14688409      PMCID: PMC314169          DOI: 10.1073/pnas.2237267100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell.

Authors:  G J Babcock; D Hochberg; A D Thorley-Lawson
Journal:  Immunity       Date:  2000-10       Impact factor: 31.745

Review 2.  Epstein-Barr virus: exploiting the immune system.

Authors:  D A Thorley-Lawson
Journal:  Nat Rev Immunol       Date:  2001-10       Impact factor: 53.106

3.  The dispersal of mucosal memory B cells: evidence from persistent EBV infection.

Authors:  Lauri L Laichalk; Donna Hochberg; Gregory J Babcock; Richard B Freeman; David A Thorley-Lawson
Journal:  Immunity       Date:  2002-05       Impact factor: 31.745

4.  EBV persistence involves strict selection of latently infected B cells.

Authors:  A M Joseph; G J Babcock; D A Thorley-Lawson
Journal:  J Immunol       Date:  2000-09-15       Impact factor: 5.422

5.  Epstein-Barr (EB) virus genome-containing, EB nuclear antigen-negative B-lymphocyte populations in blood in acute infectious mononucleosis.

Authors:  D H Crawford; A B Rickinson; S Finerty; M A Epstein
Journal:  J Gen Virol       Date:  1978-03       Impact factor: 3.891

Review 6.  A model for persistent infection with Epstein-Barr virus: the stealth virus of human B cells.

Authors:  D A Thorley-Lawson; G J Babcock
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

7.  Mitotic EBNA-positive lymphocytes in peripheral blood during infectious mononucleosis.

Authors:  J Robinson; D Smith; J Niederman
Journal:  Nature       Date:  1980-09-25       Impact factor: 49.962

8.  Characterization of the major Epstein-Barr virus-specific RNA in Burkitt lymphoma-derived cells.

Authors:  J R Arrand; L Rymo
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

9.  Lack of deleterious somatic mutations in the CD95 gene of plasmablasts from systemic lupus erythematosus patients and autoantibody-producing cell lines.

Authors:  Julia Kurth; Andreas Perniok; Roland Schmitz; Christof Iking-Konert; Nicholas Chiorazzi; Keith M Thompson; Thomas Winkler; Klaus Rajewsky; Ralf Küppers
Journal:  Eur J Immunol       Date:  2002-12       Impact factor: 5.532

10.  Plasmacytic differentiation of circulating Epstein-Barr virus-infected B lymphocytes during acute infectious mononucleosis.

Authors:  J E Robinson; D Smith; J Niederman
Journal:  J Exp Med       Date:  1981-02-01       Impact factor: 14.307

View more
  115 in total

1.  Contributions of CTCF and DNA methyltransferases DNMT1 and DNMT3B to Epstein-Barr virus restricted latency.

Authors:  David J Hughes; Elessa M Marendy; Carol A Dickerson; Kristen D Yetming; Clare E Sample; Jeffery T Sample
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Acute infection with Epstein-Barr virus targets and overwhelms the peripheral memory B-cell compartment with resting, latently infected cells.

Authors:  Donna Hochberg; Tatyana Souza; Michelle Catalina; John L Sullivan; Katherine Luzuriaga; David A Thorley-Lawson
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 3.  EBV Persistence--Introducing the Virus.

Authors:  David A Thorley-Lawson
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

Review 4.  Epstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developments.

Authors:  Lingyun Geng; Xin Wang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

5.  A model of host response to a multi-stage pathogen.

Authors:  Edgar Delgado-Eckert; Michael Shapiro
Journal:  J Math Biol       Date:  2010-10-02       Impact factor: 2.259

6.  Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo.

Authors:  Lauri L Laichalk; David A Thorley-Lawson
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 7.  The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.

Authors:  Chi Man Tsang; Sai Wah Tsao
Journal:  Virol Sin       Date:  2015-04-21       Impact factor: 4.327

8.  Epstein-Barr virus growth/latency III program alters cellular microRNA expression.

Authors:  Jennifer E Cameron; Claire Fewell; Qinyan Yin; Jane McBride; Xia Wang; Zhen Lin; Erik K Flemington
Journal:  Virology       Date:  2008-10-31       Impact factor: 3.616

9.  Epstein-Barr virus can establish infection in the absence of a classical memory B-cell population.

Authors:  Margaret Conacher; Robin Callard; Karen McAulay; Helen Chapel; David Webster; Dinakantha Kumararatne; Anita Chandra; Gavin Spickett; Paul A Hopwood; Dorothy H Crawford
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 10.  Immune escape by Epstein-Barr virus associated malignancies.

Authors:  Christian Münz; Ann Moormann
Journal:  Semin Cancer Biol       Date:  2008-10-19       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.